We hypothesized that infants born to mothers with CF taking ETI (ETI-exposed) while pregnant may have lower concentrations of IRT than newborns with CF, CFTR-related metabolic syndrome/CF screen positive, inconclusive diagnosis (CRMS/CFSPID), or CF carriers. The gene discussed is CFTR; the disease is metabolic syndrome.